Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Can i take anti histamine with statin?
Albendazole side effects in humans?
Complera manufacturer?
Novartis patent term dabrafenib?
Drugpatentwatch market analysis industry today?

Acalabrutinib fda approval date october 31 2017?

See the DrugPatentWatch profile for Acalabrutinib

Was acalabrutinib approved by the FDA on October 31, 2017?

Yes. The FDA approved acalabrutinib on October 31, 2017. [1]

How was it approved (what indication was first)?

The FDA approval on October 31, 2017 was for acalabrutinib to treat mantle cell lymphoma (MCL) that has been treated previously. [1]

Where does this date come from?

This approval date is listed in the FDA approval records for acalabrutinib (Calquence). [1]

Sources

[1] https://www.fda.gov/drugs/resources-information-approved-drugs/acalabrutinib-calquence



Other Questions About Acalabrutinib :

acalabrutinib fda approval history drugs.com Acalabrutinib approval date? Acalabrutinib fda approval date 2017? Acalabrutinib lek? Acalabrutinib fda approval october 31 2017 calquence? Acalabrutinib fda approval date calquence? Acalabrutinib fda approval?

AI-Drug Label Prescribing Information Alignment Report

Try it Free